Chatelain P, Gillet L, Waelbroeck M, Camus J C, Robberecht P, Christophe J
Horm Metab Res. 1983 Dec;15(12):620-2. doi: 10.1055/s-2007-1018808.
Secretin stimulation of adenylate cyclase activity in heart membranes was selectively altered in streptozotocin-diabetic adult male rats suffering from moderately severe diabetes, 40 days after i.v. streptozotocin administration (40 mg/kg body weight). The efficacy of secretin was reduced by 55% whilst its potency was unaffected. By contrast, the stimulation of adenylate cyclase by NaF, GTP, Gpp(NH)p, D,L-isoproterenol, and glucagon remained normal. The present data, together with the markedly reduced secretin response of cardiac adenylate cyclase in genetically obese (fa/fa) Zucker rats might indicate that hypoinsulinemia and insulin resistance both reduce the number of secretin receptors coupled to the adenylate cyclase system, an alteration whose contribution to diabetic cardiomyopathy remains to be determined.
在静脉注射链脲佐菌素(40mg/kg体重)40天后,患有中度严重糖尿病的链脲佐菌素诱导的成年雄性糖尿病大鼠心脏膜中,促胰液素对腺苷酸环化酶活性的刺激作用发生了选择性改变。促胰液素的功效降低了55%,而其效力未受影响。相比之下,氟化钠、鸟苷三磷酸(GTP)、鸟苷-5'-三磷酸(Gpp(NH)p)、D,L-异丙肾上腺素和胰高血糖素对腺苷酸环化酶的刺激作用仍保持正常。目前的数据,以及遗传性肥胖(fa/fa) Zucker大鼠心脏腺苷酸环化酶对促胰液素的反应明显降低,可能表明低胰岛素血症和胰岛素抵抗都会减少与腺苷酸环化酶系统偶联的促胰液素受体数量,这种改变对糖尿病性心肌病的影响尚待确定。